Dose escalation, which is standard practice with most GLP-1 medications, helps to optimise therapeutic effects whilst minimising gastrointestinal side effects
It is metabolically active tissue that plays a central role in insulin sensitivity, resting metabolic rate, and the capacity to sustain weight loss over time
23 Another approach is the use of novel excipients
Other causes include stenotic lesions (aortic and pulmonary stenosis, coarctation of the aorta, tetralogy of Fallot) or relative pulmonary stenosis due to increased flow from an ASD Crescendo decrescendo murmur b) Holosystolic (regurgitant) murmurs start at the beginning of S1 (pulse) and continue to S2
Bariatric Surgery: Understanding the Limitations While GLP-1 agonists have revolutionized the approach to weight loss, its critical to understand that their efficacy has limitations, particularly in individuals with morbid obesity (Body Mass Index [BMI] 40 kg/m)